Compare MGYR & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | RANI |
|---|---|---|
| Founded | 1922 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 126.8M |
| IPO Year | 2021 | 2021 |
| Metric | MGYR | RANI |
|---|---|---|
| Price | $16.10 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 8.5K | ★ 871.5K |
| Earning Date | 04-29-2026 | 03-26-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ 26.83 | 21.05 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $1,028,000.00 |
| Revenue This Year | N/A | $414.59 |
| Revenue Next Year | N/A | $30.15 |
| P/E Ratio | $34.40 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.52 | $0.39 |
| 52 Week High | $20.00 | $3.87 |
| Indicator | MGYR | RANI |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 31.11 |
| Support Level | $16.81 | $1.07 |
| Resistance Level | $17.21 | $1.54 |
| Average True Range (ATR) | 0.35 | 0.08 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 18.95 | 1.61 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.